CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 酒石酸溴莫尼定Brimonidine Tartrate
Brimonidine Tartrate

酒石酸溴莫尼定 杂质对照品Brimonidine Tartrate Impurities

EP31 个杂质条目31 impurity entries

本页汇总 酒石酸溴莫尼定 的 31 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 31 impurity reference standards of Brimonidine Tartrate with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 酒石酸溴莫尼定(Brimonidine Tartrate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA stability-indicating RP-HPLC method for the simultaneous quantification of brimonidine tartrate and timolol maleate in bulk drug substances and pharmaceutical dosage forms
    Scientific reports · 2026 · Mestareehi A  ·  PMID 41491002  ·  DOI
  2. 杂质研究Impurity studiesA Simple Validated LC-UV Method for the Simultaneous Determination of Brimonidine and Brinzolamide in the Presence of Brinzolamide's Degradation Product (Major Metabolite) in Rabbit Aqueous Humor
    Journal of chromatographic science · 2025 · Wahab Mubarak MA et al.  ·  PMID 38862397  ·  DOI
  3. 杂质研究Impurity studiesIsolation and characterization of thermal degradation impurity in brimonidine tartrate by HPLC, LC-MS/MS, and 2DNMR
    Journal of pharmaceutical and biomedical analysis · 2021 · Baksam V et al.  ·  PMID 34391137  ·  DOI
  4. 分析方法Analytical MethodsHPLC-MS/MS studies of brimonidine in rabbit aqueous humor by microdialysis
    Bioanalysis · 2021 · Tang Z et al.  ·  PMID 34601888  ·  DOI
  5. 分析方法Analytical MethodsA New UPLC Method with Chemometric Design-Optimization Approach for the Simultaneous Quantitation of Brimonidine Tartrate and Timolol Maleate in an Eye Drop Preparation
    Journal of chromatographic science · 2017 · Büker E, Dinç E  ·  PMID 27881494  ·  DOI

酒石酸溴莫尼定 —— 原料药与杂质对照品Brimonidine Tartrate — drug substance & impurities

共 32 个条目(含原料药本体)32 items incl. the drug substance
Brimonidine Tartrate structure
EP原料药 APIAPI
酒石酸溴莫尼定Brimonidine Tartrate
Brimonidine Tartrate
CAS No.—
Chemical FormulaC11H10BrN5·C4H6O6
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 1 (Brimonidine Tartrate EP Impurity A) structure
EPA
酒石酸溴莫尼定杂质1(酒石酸溴莫尼定EP杂质A)Brimonidine Tartrate Impurity 1 (Brimonidine Tartrate EP Impurity A)
Brimonidine Tartrate Impurity 1 (Brimonidine Tartrate EP Impurity A)
CAS No.91147-43-2
Chemical FormulaC11H11N5
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 2 (Brimonidine Tartrate EP Impurity B) structure
EPB
酒石酸溴莫尼定杂质2 (酒石酸溴莫尼定EP杂质B)Brimonidine Tartrate Impurity 2 (Brimonidine Tartrate EP Impurity B)
Brimonidine Tartrate Impurity 2 (Brimonidine Tartrate EP Impurity B)
CAS No.50358-63-9
Chemical FormulaC8H6BrN3
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 3 (Brimonidine Tartrate EP Impurity C) structure
EPC
酒石酸溴莫尼定杂质3(酒石酸溴莫尼定EP杂质C)Brimonidine Tartrate Impurity 3 (Brimonidine Tartrate EP Impurity C)
Brimonidine Tartrate Impurity 3 (Brimonidine Tartrate EP Impurity C)
CAS No.6298-37-9
Chemical FormulaC8H7N3
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 4 (Brimonidine Tartrate EP Impurity D) structure
EPD
酒石酸溴莫尼定杂质4(酒石酸溴莫尼定EP杂质D)Brimonidine Tartrate Impurity 4 (Brimonidine Tartrate EP Impurity D)
Brimonidine Tartrate Impurity 4 (Brimonidine Tartrate EP Impurity D)
CAS No.842138-74-3
Chemical FormulaC9H7BrN4S
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 5 (Brimonidine Tartrate EP Impurity E) structure
EPE
酒石酸溴莫尼定杂质5(酒石酸溴莫尼定EP杂质E)Brimonidine Tartrate Impurity 5 (Brimonidine Tartrate EP Impurity E)
Brimonidine Tartrate Impurity 5 (Brimonidine Tartrate EP Impurity E)
CAS No.168329-48-4
Chemical FormulaC9H8BrN5
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 6 (Brimonidine Tartrate EP Impurity F) structure
EPF
酒石酸溴莫尼定杂质6(酒石酸溴莫尼定EP杂质F)Brimonidine Tartrate Impurity 6 (Brimonidine Tartrate EP Impurity F)
Brimonidine Tartrate Impurity 6 (Brimonidine Tartrate EP Impurity F)
CAS No.151110-15-5
Chemical FormulaC11H8BrN5
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 7 Monomer (Brimonidine Tartrate EP Impurity G) structure
EPG
酒石酸溴莫尼定杂质7 单体 (酒石酸溴莫尼定EP杂质G)Brimonidine Tartrate Impurity 7 Monomer (Brimonidine Tartrate EP Impurity G)
Brimonidine Tartrate Impurity 7 Monomer (Brimonidine Tartrate EP Impurity G)
CAS No.1216379-05-3
Chemical FormulaC11H12BrN5O
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 7 (Brimonidine Tartrate EP Impurity G Trifluoroacetate) structure
EPG
酒石酸溴莫尼定杂质7 (酒石酸溴莫尼定EP杂质G 三氟乙酸盐)Brimonidine Tartrate Impurity 7 (Brimonidine Tartrate EP Impurity G Trifluoroacetate)
Brimonidine Tartrate Impurity 7 (Brimonidine Tartrate EP Impurity G Trifluoroacetate)
CAS No.1391054-10-6
Chemical FormulaC11H12BrN5O·C2HF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine-d4 structure
—
溴莫尼定-d4Brimonidine-d4
Brimonidine-d4
CAS No.1184971-51-4
Chemical FormulaC11H6D4BrN5
Purity>95%询价On request
Brimonidine Tartrate-d4 structure
—
酒石酸溴莫尼定-d4Brimonidine Tartrate-d4
Brimonidine Tartrate-d4
CAS No.1316758-27-6
Chemical FormulaC11H6D4BrN5·C4H6O6
Purity>95%询价On request
Brimonidine D-Tartrate structure
—
D-酒石酸溴莫尼定Brimonidine D-Tartrate
Brimonidine D-Tartrate
CAS No.1400635-36-0
Chemical FormulaC11H10BrN5·C4H6O6
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine structure
—
溴莫尼定Brimonidine
Brimonidine
CAS No.59803-98-4
Chemical FormulaC11H10BrN5
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine L-Tartrate structure
—
L-酒石酸溴莫尼定Brimonidine L-Tartrate
Brimonidine L-Tartrate
CAS No.70359-46-5
Chemical FormulaC11H10BrN5·C4H6O6
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 8 structure
8
酒石酸溴莫尼定杂质8Brimonidine Tartrate Impurity 8
Brimonidine Tartrate Impurity 8
CAS No.91147-46-5
Chemical FormulaC11H10ClN5
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 11 structure
11
酒石酸溴莫尼定杂质11Brimonidine Tartrate Impurity 11
Brimonidine Tartrate Impurity 11
CAS No.135306-56-8
Chemical FormulaC9H5N3S
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 13 structure
13
酒石酸溴莫尼定杂质13Brimonidine Tartrate Impurity 13
Brimonidine Tartrate Impurity 13
CAS No.182628-02-0
Chemical FormulaC9H5BrN4
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 17 structure
17
酒石酸溴莫尼定杂质17Brimonidine Tartrate Impurity 17
Brimonidine Tartrate Impurity 17
CAS No.842138-75-4
Chemical FormulaC11H10BrN3OS
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 19 structure
19
酒石酸溴莫尼定杂质19Brimonidine Tartrate Impurity 19
Brimonidine Tartrate Impurity 19
CAS No.185312-10-1
Chemical FormulaC11H9N5
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 21 structure
21
酒石酸溴莫尼定杂质21Brimonidine Tartrate Impurity 21
Brimonidine Tartrate Impurity 21
CAS No.934548-66-0
Chemical FormulaC15H12BrN5O3
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 22 structure
22
酒石酸溴莫尼定杂质22Brimonidine Tartrate Impurity 22
Brimonidine Tartrate Impurity 22
CAS No.134892-47-0
Chemical FormulaC11H12BrN5S
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 23 structure
23
酒石酸溴莫尼定杂质23Brimonidine Tartrate Impurity 23
Brimonidine Tartrate Impurity 23
CAS No.135306-57-9
Chemical FormulaC11H13N5S
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 27 structure
27
酒石酸溴莫尼定杂质27Brimonidine Tartrate Impurity 27
Brimonidine Tartrate Impurity 27
CAS No.1378255-24-3
Chemical FormulaC8H6BrN3
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 28 structure
28
酒石酸溴莫尼定杂质28Brimonidine Tartrate Impurity 28
Brimonidine Tartrate Impurity 28
CAS No.1217439-05-8
Chemical FormulaC9H7BrN4S
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 34 structure
34
酒石酸溴莫尼定杂质34Brimonidine Tartrate Impurity 34
Brimonidine Tartrate Impurity 34
CAS No.1436426-14-0
Chemical FormulaC8H6BrN3
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 36 structure
36
酒石酸溴莫尼定杂质36Brimonidine Tartrate Impurity 36
Brimonidine Tartrate Impurity 36
CAS No.134862-75-2
Chemical FormulaC11H12BrN5
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 40 structure
40
酒石酸溴莫尼定杂质40Brimonidine Tartrate Impurity 40
Brimonidine Tartrate Impurity 40
CAS No.1158184-23-6
Chemical FormulaC13H12BrN5O
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 50 structure
50
酒石酸溴莫尼定杂质50Brimonidine Tartrate Impurity 50
Brimonidine Tartrate Impurity 50
CAS No.6639-91-4
Chemical FormulaC8H11N3
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 54 structure
54
酒石酸溴莫尼定杂质54Brimonidine Tartrate Impurity 54
Brimonidine Tartrate Impurity 54
CAS No.6639-87-8
Chemical FormulaC8H5N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 55 structure
55
酒石酸溴莫尼定杂质55Brimonidine Tartrate Impurity 55
Brimonidine Tartrate Impurity 55
CAS No.1287747-30-1
Chemical FormulaC8H6ClN3
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 58 structure
58
酒石酸溴莫尼定杂质58Brimonidine Tartrate Impurity 58
Brimonidine Tartrate Impurity 58
CAS No.2768536-86-1
Chemical FormulaC12H11BrN6O
Purity>95%询价On request
10mg25mg50mg100mg
Brimonidine Tartrate Impurity 59 structure
59
酒石酸溴莫尼定杂质59Brimonidine Tartrate Impurity 59
Brimonidine Tartrate Impurity 59
CAS No.2768536-87-2
Chemical FormulaC12H13BrN6O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

酒石酸溴莫尼定 —— 研究文献与合成路线Brimonidine Tartrate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 酒石酸溴莫尼定 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Brimonidine Tartrate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Isolation and characterization of thermal degradation impurity in brimonidine tartrate by HPLC, LC-MS/MS, and 2DNMR
    Baksam V, Nimmakayala S, Devineni SR, et al. · Journal of pharmaceutical and biomedical analysis · 2021 · 被引 3cited 3
  2. Single quad mass analyzer coupled UPLC method for impurity profile of Brimonidine tartrate and Timolol maleate: Application in their binary mixture ophthalmic formulation
    Kondra S, Akula Thukaram B, Gowrisankar D, et al. · Annales pharmaceutiques francaises · 2021
  3. A stability-indicating RP-HPLC method for the simultaneous quantification of brimonidine tartrate and timolol maleate in bulk drug substances and pharmaceutical dosage forms
    Mestareehi A · Scientific reports · 2026
  4. Development and Validation of a Robust Stability-Indicating Reversed Phase High Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantification of Brimonidine Tartrate and Timolol Maleate (Combigan ® ) in Bulk and Pharmaceutical Dosage Forms
    Mestareehi A · 2025

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

酒石酸溴莫尼定 杂质谱研究要点Brimonidine Tartrate — impurity profiling notes

下面这些是拿到 酒石酸溴莫尼定 的 32 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 32 impurity entries for Brimonidine Tartrate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances